Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children

Almeida, Flávia J; Berezin, Eitan N; Rodrigues, Rosángela; Sáfadi, Marco A. P; Arnoni, Mariana V; Oliveira, Cristina; Brígido, Luis F. M.
Rev. chil. pediatr ; 82(5): 462-462, oct. 2011.
Artigo em Inglês | LILACS | ID: lil-612178

Documentos relacionados

  1. Executive summary. Consensus document of GESIDA and SPNS (Spanish Secretariat for the National Plan on AIDS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)
  2. Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.
  3. "I feel drug resistance testing allowed us to make an informed decision": qualitative insights on the role of HIV drug resistance mutation testing among children and pregnant women living with HIV in western Kenya.
  4. An exploratory investigation of the CSF metabolic profile of HIV in a South African paediatric cohort using GCxGC-TOF/MS.
  5. Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance.
  6. Immunogenicity and Safety of the Measles Vaccine in HIV-Infected Children: An Updated Systematic Review.
  7. Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real-life experience from a French cohort (2019-2023).
  8. Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children.
  9. Mite allergen sensitization patterns in Turkish children: Age-related changes and molecular correlations.
  10. Prevalence of drug resistance in children recently diagnosed with HIV-1 infection in France (2006-17): impact on susceptibility to first-line strategies.